XML 19 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (37,594,401) $ (8,024,985)
Adjustments to reconcile net loss to net cash used in operating activities:    
Goodwill impairment charges 26,600,000  
Stock-based compensation 1,137,125 584,784
Depreciation 61,191 47,276
Amortization 40,409 60,552
Debt discount and deferred financing cost accretion 98,060 1,950,159
Loss on disposal of property and equipment 3,745  
Change in fair value of warrant liabilities 508,316  
Change in fair value of embedded derivatives 1,157  
Changes in operating assets and liabilities:    
Accounts receivable (1,393,988) (103,308)
Prepaid expenses and other current assets (150,524) 67,465
Accounts payable (2,273,397) 925,664
Accrued expenses and other current liabilities (34,680) 80,668
Deferred revenue (14,815) (70,705)
Deferred rent (10,085) (5,971)
Tax refund receivable (2,142,987) (371,715)
Deferred tax liability (243,056)  
Net cash used in operating activities (15,407,930) (4,860,116)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (89,849) (113,040)
Proceeds from sale of property and equipment 7,531  
Additions to intangible assets (47,634) (66,307)
Refund of cash held in escrow 200,000  
Cash assumed from acquiring subsidiaries 13,684,535  
Net cash provided by (used in) investing activities 13,754,583 (179,347)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments of notes payable (212,431) (99)
Proceeds from issuance of convertible notes, net of issuance costs 3,018,780 531
Proceeds from issuance of preferred stock and warrants, net of issuance costs 13,018,570 5,673,680
Proceeds from exercise of stock options 16,455 300
Net cash provided by financing activities 15,841,374 5,674,412
EFFECT OF EXCHANGE RATES ON CASH 86,879 (170,048)
Net increase in cash and cash equivalents and restricted cash 14,274,906 464,901
Cash and cash equivalents and restricted cash, beginning of period 2,876,113 4,638,711
Cash and cash equivalents and restricted cash, end of period 17,151,019 5,103,612
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 5,882 2,424
SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES:    
Accrued expenses and notes payable modified and replaced with convertible notes 1,077,540  
Conversion of convertible notes into common stock 3,645,424  
Common stock warrants issued in connection with convertible notes, net of issuance costs $ 548,956  
Preferred stock subscription reclassified as additional paid-in capital upon preferred stock issuance   $ 325,280